We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $375M
1-Year Est. Return 131.24%
This Fund
S&P 500
This Quarter Est. Return
+13.22%
1 Year Est. Return
+131.24%
3 Year Est. Return
+400.69%
5 Year Est. Return
+687.84%
10 Year Est. Return
AUM
$106M
AUM Growth
+$18.4M
Cap. Flow
+$7.78M
Cap. Flow %
7.34%
Top 10 Hldgs %
47.47%
Holding
62
New
7
Increased
12
Reduced
31
Closed
8

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$4.93M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$3.44M
3
AMGN icon
Amgen
AMGN
+$3.13M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.45M
5
LLY icon
Eli Lilly
LLY
+$1.45M

Sector Composition

Rank Sector Weight
1 Healthcare 26.81%
2 Energy 19.37%
3 Miscellaneous 18.37%
4 Consumer Staples 14.5%
5 Industrials 11.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GFI icon
51
Gold Fields
GFI
$40.2B
$259K 0.24%
+25,000
New +$242K
PSLV icon
52
Sprott Physical Silver Trust
PSLV
$13.2B
$247K 0.23%
+30,000
New +$219K
CWB icon
53
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.63B
$235K 0.22%
3,651
-1,893
-34% -$123K
BTG icon
54
B2Gold
BTG
$7.11B
$179K 0.17%
50,000
AMT icon
55
American Tower
AMT
$82.9B
-7,420
Closed -$1.59M
AMZN icon
56
Amazon
AMZN
$2.77T
-2,125
Closed -$240K
AVGO icon
57
Broadcom
AVGO
$1.73T
-8,000
Closed -$355K
BTT icon
58
BlackRock Municipal 2030 Target Term Trust
BTT
$1.42B
-126,406
Closed -$2.59M
CSL icon
59
Carlisle Companies
CSL
$13.3B
-1,901
Closed -$533K
DVN icon
60
Devon Energy
DVN
$55.3B
-5,000
Closed -$301K
FLNG icon
61
FLEX LNG
FLNG
$1.71B
-8,000
Closed -$253K
OXY icon
62
Occidental Petroleum
OXY
$61.4B
-8,500
Closed -$522K

Similar funds

Geneva Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Geneva Partners held 62 positions worth $106M, up 21% from $87.5M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Geneva Partners deployed $7.78M of net new capital in Q4 2022, opening 7 new positions and adding to 12 existing holdings. Its largest new stake was Eli Lilly: 4,090 shares worth $1.5M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Energy and Miscellaneous.

On the sell side, the largest reduction was UnitedHealth, an estimated $937K trimmed.

  • Geneva Partners's largest Q4 2022 buy was Eli Lilly: 4,090 shares worth $1.5M.
  • Geneva Partners added most to Merck in Q4 2022, an estimated $4.93M increase.
  • Geneva Partners's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $937K.
  • Geneva Partners fully exited BlackRock Municipal 2030 Target Term Trust in Q4 2022, selling an estimated $2.59M.
  • Geneva Partners's ten largest holdings make up 47% of its $106M portfolio in Q4 2022.
  • Geneva Partners opened 7 new positions and closed 8 in Q4 2022.
  • Geneva Partners's portfolio value rose 21% quarter-over-quarter to $106M.

Based on Geneva Partners's 13F filing for Q4 2022, filed 23 Jan 2023.